Large drugmakers may not deliver mind-blowing growth, but they can certainly provide the peace of mind that allows investors to get a good night’s sleep. These large drugmakers, more commonly known as “Big Pharma,” often pay market-topping dividends and tend to be largely recession-resistant, which makes them particularly attractive to long-term investors.
With this in mind, we asked three of our healthcare-focused Foolish contributors what Big Pharma stock they believe could be worth your investment dollars.
